@article{9bb4532411bf4fbbb2711f90fece5713,
title = "Reply to Letter to the Editor Regarding “Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss After Spinal Cord Injury: A Randomized, Controlled Trial”",
author = "Edwards, {W. Brent} and Haider, {Ifaz T.} and Narina Simonian and Joana Barroso and Schnitzer, {Thomas J.}",
note = "Funding Information: W. Brent Edwards has received research funding and speaker fees from Amgen. Thomas J. Schnitzer has received research funding from Radius, Amgen, Eli Lilly, and Pfizer as well as consulting fees from Eli Lilly and Pfizer. Ifaz T. Haider, Narina Simonian, and Joana Barroso have no competing interests to declare.",
year = "2022",
month = jan,
doi = "10.1002/jbmr.4456",
language = "English (US)",
volume = "37",
pages = "169--170",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "1",
}
